Abbott Structural Heart Division was founded in April, 2016 by acquiring  St. Jude Medical. St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. The company was named after Jude the Apostle, the patron saint of lost causes.

In October 1977, Dr. Nicoloff implanted the company's first artificial heart valve in a human patient. St. Jude Medical's new heart valve was coated in pyrolytic carbon, which helped the valve prevent blood clotting.

The Abbott portfolio of structural heart solutions has expanded significantly in recent years, featuring products to treat the broad spectrum of structural heart disease (SHD)—encompassing both congenital heart defects and acquired conditions, such as valvular heart disease.

For more than 130 years, we've put science and innovation to work – to create more possibilities for more people through the power of health. We adapt and respond quickly to changes in the world around us to deliver better solutions to help people live their best lives.

Abbott has long philanthropic history. We view philanthropy as a powerful source for driving social innovations that lead to more resilient, healthier communities.

Abbott is proud sponsor of London Marathon.

life.to the fullest